In vivo efficacy of NY-ESO-1 plus adjuvant

Details for Australian Patent Application No. 2004277402 (hide)

Owner Ludwig Institute For Cancer Research CSL Limited

Inventors Green, Simon; Cebon, Jonathan; Chen, Weisan; Davis, Ian

Agent Davies Collison Cave

Pub. Number AU-B-2004277402

PCT Pub. Number WO2005/032475

Priority 60/507,175 30.09.03 US; 60/572,543 18.05.04 US

Filing date 30 September 2004

Wipo publication date 14 April 2005

Acceptance publication date 25 November 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/032475 Priority application(s): WO2005/032475

25 November 2010 Application Accepted

  Published as AU-B-2004277402

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004277403-Polybiotin compounds for magnetic resonance imagining and drug delivery

2004277401-Process for enzymatic treatment and filtration of a plant and products obtainable thereby